iCo Therapeutics Inc (OTCMKTS:ICOTF)’s stock price crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.08 and traded as low as $0.09. iCo Therapeutics shares last traded at $0.11, with a volume of 20,715 shares changing hands.
The stock has a 50-day simple moving average of $0.08 and a 200-day simple moving average of $0.06.
iCo Therapeutics Company Profile (OTCMKTS:ICOTF)
iCo Therapeutics Inc, a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat sight and life threatening diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat sight threatening ocular allergies and various systemic disease indications; and Oral AmpB Delivery System that is in pre-clinical stage used for the treatment of systemic fungal infections.
Read More: Management Fee
Receive News & Ratings for iCo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.